Impact of estrogen receptor beta activation on functional recovery after experimental stroke

Behavioural Brain Research

Volumn 261, Issue , 2014, Pages 282-288

  Madinier, Alexandre ^a   Wieloch, Tadeusz ^a   Olsson, Roger ^b   Ruscher, Karsten ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

AC 131; Cerebral ischemia; Estrogen receptor beta; Hormone therapy; Photothrombosis; Stroke recovery

Indexed keywords

4 (1 PHENYLCYCLOHEXYL)PHENOL; AC 131; CENTRAL NERVOUS SYSTEM AGENTS; ESTROGEN RECEPTOR BETA; UNCLASSIFIED DRUG;

ADHESIVE REMOVAL TEST; ADULT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; EXPERIMENTAL STROKE; FUNCTIONAL ASSESSMENT; GRIP STRENGTH; MALE; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; RAT; SCORING SYSTEM;

AC-131; CEREBRAL ISCHEMIA; ESTROGEN RECEPTOR BETA; HORMONE THERAPY; PHOTOTHROMBOSIS; STROKE RECOVERY;

ANIMALS; BRAIN INFARCTION; CYCLOHEXANES; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTROGEN RECEPTOR BETA; ESTROGEN RECEPTOR MODULATORS; INTRACRANIAL THROMBOSIS; MALE; MUSCLE STRENGTH; PHENOLS; PSYCHOMOTOR PERFORMANCE; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; STATISTICS, NONPARAMETRIC; STROKE; TIME FACTORS;

EID: 84892454735     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2013.12.046     Document Type: Article

References (60)

1. Nudo R.J. Neural bases of recovery after brain injury. J Commun Disord 2011, 44:515-520.
2. Brewer L., Horgan F., Hickey A., Williams D. Stroke rehabilitation: recent advances and future therapies. Q J Med 2013, 106:11-25.
3. Kitago T., Liang J., Huang V.S., Hayes S., Simon P., Tenteromano L., et al. Improvement after constraint-induced movement therapy: recovery of normal motor control or task-specific compensation. Neurorehab Neural Repair 2013, 27:99-109.
4. Fritz S.L., Butts R.J., Wolf S.L. Constraint-induced movement therapy: from history to plasticity. Expert Rev Neurother 2012, 12:191-198.
5. Hsu S.S., Hu M.H., Luh J.J., Wang Y.H., Yip P.K., Hsieh C.L. Dosage of neuromuscular electrical stimulation: is it a determinant of upper limb functional improvement in stroke patients. J Rehabil Med 2012, 44:125-130.
6. Edwardson M.A., Lucas T.H., Carey J.R., Fetz E.E. New modalities of brain stimulation for stroke rehabilitation. Exp Brain Res 2013, 224:335-358.
7. Schneider A., Wysocki R., Pitzer C., Kruger C., Laage R., Schwab S., et al. An extended window of opportunity for G-CSF treatment in cerebral ischemia. BMC Biol 2006, 4:36.
8. Belayev L., Khoutorova L., Zhao K.L., Davidoff A.W., Moore A.F., Cramer S.C. A novel neurotrophic therapeutic strategy for experimental stroke. Brain Res 2009, 1280:117-123.
9. Ruscher K., Shamloo M., Rickhag M., Ladunga I., Soriano L., Gisselsson L., et al. The sigma-1 receptor enhances brain plasticity and functional recovery after experimental stroke. Brain 2011, 134:732-746.
10. Ruscher K., Kuric E., Liu Y., Walter H.L., Issazadeh-Navikas S., Englund E., et al. Inhibition of CXCL12 signaling attenuates the postischemic immune response and improves functional recovery after stroke. J Cereb Blood Flow Metab 2013, 33:1225-1234.
11. Subramanian S., Zhang B., Kosaka Y., Burrows G.G., Grafe M.R., Vandenbark A.A., et al. Recombinant T cell receptor ligand treats experimental stroke. Stroke 2009, 40:2539-2545.
12. Ruscher K., Kuric E., Wieloch T. Levodopa treatment improves functional recovery after experimental stroke. Stroke 2012, 43:507-513.
13. Dhawan J., Benveniste H., Luo Z., Nawrocky M., Smith S.D., Biegon A. A new look at glutamate and ischemia: NMDA agonist improves long-term functional outcome in a rat model of stroke. Future Neurol 2011, 6:823-834.
14. Wang L.E., Fink G.R., Diekhoff S., Rehme A.K., Eickhoff S.B., Grefkes C. Noradrenergic enhancement improves motor network connectivity in stroke patients. Ann Neurol 2011, 69:375-388.
15. Pearson-Fuhrhop K.M., Minton B., Acevedo D., Shahbaba B., Cramer S.C. Genetic variation in the human brain dopamine system influences motor learning and its modulation by l-Dopa. PLOS One 2013, 8:e61197.
16. Viscoli C.M., Brass L.M., Kernan W.N., Sarrel P.M., Suissa S., Horwitz R.I. A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med 2001, 345:1243-1249.
17. Wassertheil-Smoller S., Hendrix S.L., Limacher M., Heiss G., Kooperberg C., Baird A., et al. Effect of estrogen plus progestin on stroke in postmenopausal women: the women's health initiative: a randomized trial. J Am Med Assoc 2003, 289:2673-2684.
18. Merchenthaler I., Dellovade T.L., Shughrue P.J. Neuroprotection by estrogen in animal models of global and focal ischemia. Ann NY Acad Sci 2003, 1007:89-100.
19. Dubal D.B., Kashon M.L., Pettigrew L.C., Ren J.M., Finklestein S.P., Rau S.W., et al. Estradiol protects against ischemic injury. J Cereb Blood Flow Metab 1998, 18:1253-1258.
20. Fukuda K., Yao H., Ibayashi S., Nakahara T., Uchimura H., Fujishima M., et al. Ovariectomy exacerbates and estrogen replacement attenuates photothrombotic focal ischemic brain injury in rats. Stroke 2000, 31:155-160.
21. Simpkins J.W., Yang S.H., Liu R., Perez E., Cai Z.Y., Covey D.F., et al. Estrogen-like compounds for ischemic neuroprotection. Stroke 2004, 35:2648-2651.
22. Behl C., Widmann M., Trapp T., Holsboer F. 17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem Biophys Res Commun 1995, 216:473-482.
23. McCullough L.D., Alkayed N.J., Traystman R.J., Williams M.J., Hurn P.D. Postischemic estrogen reduces hypoperfusion and secondary ischemia after experimental stroke. Stroke 2001, 32:796-802.
24. Dubal D.B., Shughrue P.J., Wilson M.E., Merchenthaler I., Wise P.M. Estradiol modulates bcl-2 in cerebral ischemia: a potential role for estrogen receptors. J Neurosci 1999, 19:6385-6393.
25. Mohamed M.K., Abdel-Rahman A.A. Effect of long-term ovariectomy and estrogen replacement on the expression of estrogen receptor gene in female rats. Eur J Endocrinol 2000, 142:307-314.
26. Schreihofer D.A., Ma Y. Estrogen receptors and ischemic neuroprotection: who, what, where, and when. Brain Res 2013, 1514:107-122.
27. Li J., Siegel M., Yuan M., Zeng Z., Finnucan L., Persky R., et al. Estrogen enhances neurogenesis and behavioral recovery after stroke. J Cereb Blood Flow Metab 2011, 31:413-425.
28. Soderstrom I., Strand M., Ingridsson A.C., Nasic S., Olsson T. 17beta-estradiol and enriched environment accelerate cognitive recovery after focal brain ischemia. Eur J Neurosci 2009, 29:1215-1224.
29. Crawford D.K., Mangiardi M., Song B., Patel R., Du S., Sofroniew M.V., et al. Oestrogen receptor beta ligand: a novel treatment to enhance endogenous functional remyelination. Brain 2010, 133:2999-3016.
30. Farr T.D., Carswell H.V., Gallagher L., Condon B., Fagan A.J., Mullin J., et al. 17beta-Estradiol treatment following permanent focal ischemia does not influence recovery of sensorimotor function. Neurobiol Dis 2006, 23:552-562.
31. Auriat A., Plahta W.C., McGie S.C., Yan R., Colbourne F. 17beta-Estradiol pretreatment reduces bleeding and brain injury after intracerebral hemorrhagic stroke in male rats. J Cereb Blood Flow Metab 2005, 25:247-256.
32. Nguyen A.P., Arvanitidis A.P., Colbourne F. Failure of estradiol to improve spontaneous or rehabilitation-facilitated recovery after hemorrhagic stroke in rats. Brain Res 2008, 1193:109-119.
33. Piu F., Cheevers C., Hyldtoft L., Gardell L.R., Del Tredici A.L., Andersen C.B., et al. Broad modulation of neuropathic pain states by a selective estrogen receptor beta agonist. Eur J Pharmacol 2008, 590:423-429.
34. Gardell L.R., Hyldtoft L., Del Tredici A.L., Andersen C.B., Fairbairn L.C., Lund B.W., et al. Differential modulation of inflammatory pain by a selective estrogen receptor beta agonist. Eur J Pharmacol 2008, 592:158-159.
35. McFarland K., Price D.L., Davis C.N., Ma J.N., Bonhaus D.W., Burstein E.S., et al. AC-186, a selective nonsteroidal estrogen receptor beta agonist, shows gender specific neuroprotection in a Parkinson's disease rat model. ACS Chem Neurosci 2013.
36. De R.M., Van R.J., Duytschaever H., Van D.B., Clincke G. Neocortical localization of tactile/proprioceptive limb placing reactions in the rat. Brain Res 1992, 573:44-60.
37. Ruscher K., Johannesson E., Brugiere E., Erickson A., Rickhag M., Wieloch T. Enriched environment reduces apolipoprotein E (ApoE) in reactive astrocytes and attenuates inflammation of the peri-infarct tissue after experimental stroke. J Cereb Blood Flow Metab 2009, 29:1796-1805.
38. Farr T.D., Carswell H.V., Gsell W., Macrae I.M. Estrogen receptor beta agonist diarylpropiolnitrile (DPN) does not mediate neuroprotection in a rat model of permanent focal ischemia. Brain Res 2007, 1185:275-282.
39. Ooishi Y., Kawato S., Hojo Y., Hatanaka Y., Higo S., Murakami G., et al. Modulation of synaptic plasticity in the hippocampus by hippocampus-derived estrogen and androgen. J Steroid Biochem Mol Biol 2012, 131:37-51.
40. Mukai H., Tsurugizawa T., Murakami G., Kominami S., Ishii H., Ogiue-Ikeda M., et al. Rapid modulation of long-term depression and spinogenesis via synaptic estrogen receptors in hippocampal principal neurons. J Neurochem 2007, 100:950-967.
41. Srivastava D.P., Woolfrey K.M., Liu F., Brandon N.J., Penzes P. Estrogen receptor β activity modulates synaptic signaling and structure. J Neurosci 2010, 30:13454-13460.
42. Sun J., Chu Z., Moenter S.M. Diurnal in vivo and rapid in vitro effects of estradiol on voltage-gated calcium channels in gonadotropin-releasing hormone neurons. J Neurosci 2010, 30:3912-3923.
43. Boulware M.I., Kordasiewicz H., Mermelstein P.G. Caveolin proteins are essential for distinct effects of membrane estrogen receptors in neurons. J Neurosci 2007, 27:9941-9950.
44. Kamel H., Iadecola C. Brain-immune interactions and ischemic stroke: clinical implications. Arch Neurol 2012, 69:576-581.
45. Tiwari-Woodruff S., Morales L.B., Lee R., Voskuhl R.R. Differential neuroprotective and antiinflammatory effects of estrogen receptor (ER)alpha and ERbeta ligand treatment. Proc Natl Acad Sci USA 2007, 104:14813-14818.
46. Du S., Sandoval F., Trinh P., Umeda E., Voskuhl R. Estrogen receptor-beta ligand treatment modulates dendritic cells in the target organ during autoimmune demyelinating disease. Eur J Immunol 2011, 41:140-150.
47. Brown C.M., Mulcahey T.A., Filipek N.C., Wise P.M. Production of proinflammatory cytokines and chemokines during neuroinflammation: novel roles for estrogen receptors alpha and beta. Endocrinology 2010, 151:4916-4925.
48. Lewis D.K., Johnson A.B., Stohlgren S., Harms A., Sohrabji F. Effects of estrogen receptor agonists on regulation of the inflammatory response in astrocytes from young adult and middle-aged female rats. J Neuroimmunol 2008, 195:47-59.
49. Milner T.A., Ayoola K., Drake C.T., Herrick S.P., Tabori N.E., McEwen B.S., et al. Ultrastructural localization of estrogen receptor beta immunoreactivity in the rat hippocampal formation. J Comp Neurol 2005, 491:81-95.
50. Patkar S., Farr T.D., Cooper E., Dowell F.J., Carswell H.V. Differential vasoactive effects of oestrogen, oestrogen receptor agonists and selective oestrogen receptor modulators in rat middle cerebral artery. Neurosci Res 2011, 71:78-84.
51. Salom J.B., Burguete M.C., Perez-Asensio F.J., Torregrosa G., Alborch E. Relaxant effects of 17-beta-estradiol in cerebral arteries through Ca(2+) entry inhibition. J Cereb Blood Flow Metab 2001, 21:422-429.
52. Butera P.C. Estradiol and the control of food intake. Physiol Behav 2010, 99:175-180.
53. Rogers N.H., Perfield J.W., Strissel K.J., Obin M.S., Greenberg A.S. Reduced energy expenditure and increased inflammation are early events in the development of ovariectomy-induced obesity. Endocrinology 2009, 150:2161-2168.
54. Stubbins R.E., Holcomb V.B., Hong J., Nunez N.P. Estrogen modulates abdominal adiposity and protects female mice from obesity and impaired glucose tolerance. Eur J Nutr 2012, 51:861-870.
55. Clegg D.J. Minireview: the year in review of estrogen regulation of metabolism. Mol Endocrinol 2012, 26:1957-1960.
56. Ohlsson C., Hellberg N., Parini P., Vidal O., Bohlooly-Y M., Rudling M., et al. Obesity and disturbed lipoprotein profile in estrogen receptor-alpha-deficient male mice. Biochem Biophys Res Commun 2000, 278:640-645.
57. Meyer M.R., Clegg D.J., Prossnitz E.R., Barton M. Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors. Acta Physiol 2011, 203:259-269.
58. Liang Y.Q., Akishita M., Kim S., Ako J., Hashimoto M., Iijima K., et al. Estrogen receptor beta is involved in the anorectic action of estrogen. Int J Obes Relat Metab Disord 2002, 26:1103-1109.
59. Roesch D.M. Effects of selective estrogen receptor agonists on food intake and body weight gain in rats. Physiol Behav 2006, 87:39-44.
60. Yepuru M., Eswaraka J., Kearbey J.D., Barrett C.M., Raghow S., Veverka K.A., et al. Estrogen receptor-b-selective ligands alleviate high-fat diet- and ovariectomy-induced obesity in mice. J Biol Chem 2010, 285:31292-31303.